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SYNTHETIC PROCEDURE 
 
Materials 
All reagents were, unless otherwise noted, used as purchased. Chemicals and solvents were 
purchased from Fluka Chemie AG (D-Taufkirchen, Germany), Fisher Scientific UK Ltd. 
(Loughborough, Leics. GB), Merck KGaA (Darmstadt, Germany), Sigma-Aldrich Chemie 
GmbH (Steinheim, Germany), and ABCR (Karlsruhe, Germany). Analytical thin-layer 
chromatography was performed on TLC plates (Alugram Sil G/UV254) from Macherey-Nagel 
(Düren, Germany). Preparative column chromatography was carried out using silica gel (60 Å 
pore size, 63-200 ȝm particle size) from Merck KGaA (Darmstadt, Germany). Silicon Wafers 
(100 orientation) were provided by Crystec (Berlin, Germany). Quartz substrates Suprasil with 
a thickness of 1 mm were purchased from Heraeus Quarzglas (Hanau, Germany). 
 
Methods 
Solution 1H-NMR spectra were recorded on a Bruker Spectrospin 250 or 300 MHz. UV/VIS 
spectra were recorded with a Varian Cary 4000 UV/VIS spectrometer (Varian Inc. Palo Alto, 
USA). 
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Synthesis of Caged Organosilanes.  
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Scheme 1. Synthetic routes of the photosensitive silanes. Saturated compounds as by-products of the 
hydrosililation reaction are included. 
 
 
3-Triethoxysilylpropyl-N-(4,5-dimethoxy-2-nitrobenzyloxycarbonyl)amine (NVOC-APTS) (1) 
was prepared as reported.1 
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2-(2-Nitrophenyl)propyl allylcarbamate (2) was obtained according to previously reported 
procedure.2 NaCO3 (0.96 g) was added to the solution of allyl amine (0.31 mL, 4.10 mmol) in 
40 mL of 1,4-dioxane:water (1:1) at 0 °C, followed by the dropwise addition of 2-(2-
nitrophenyl)propyl chloroformate (1.0 g, 4.10 mmol) in 4 mL of THF. After 20 minutes the ice 
bath was removed and the reaction mixture was stirring for 24 h. The solvents were removed in 
the rotary evaporator, 3 mL of water was added and the mixture was extracted with ethyl 
acetate (2x20 mL). The aqueous layer was acidified by addition of 5% HCl (10 mL) at 0 °C 
and extracted with ethyl acetate (3x40 mL). The extracts were dried over MgSO4 and 
concentrated at reduced pressure to give an orange oil as the desired product 2 (0.96 g, 89%). 
1H NMR (CDCl3): į 7.71 (dd, J = 8.0 Hz, J = 1.1 Hz, 1H, Ar-H), 7.56 (td, J = 8.1 Hz, J = 1.3 
Hz, 1H, Ar-H), 7.47 (dd, J = 8.0 Hz, J = 1.4 Hz, 1H, Ar-H), 7.32 (td, J = 8.0 Hz, J = 1.5 Hz, 
1H, Ar-H), 5.71 (m, 1H, CH), 5.11 (m, 2H, CH2), 4.69 (br d, 1H, NH), 4.16 (dq, J = 6.1 Hz, 
2H, CH2), 3.71 (m, 1H, CH), 3.71 (m, 2H, CH2), 1.34 (d, J = 7.0 Hz, 3H, CH3). 
 
2-(2-Nitrophenyl)propyl 2-( triethoxysilyl)ethylcarbamate  (NPPOC-APTS) (3). 2-(2-
Nitrophenyl)propyl allylcarbamate (2) (0.5 g, 1.89 mmol) and triethoxysilane (3.5 mL, 18.92 
mmol) were placed into a previously HMDS-passivated3 dry, round-bottomed flask and heated 
to 80 °C under argon atmosphere. After addition of an isopropanolic H2PtCl6 solution (96 ȝL, 
65 mM), the mixture was stirred for 5 hours at 80 °C and then allowed to cool. Excess of 
triethoxysilane was removed in vacuum, and the residue was taken up in dichloromethane and 
filtered through Celite500. The filtrate was concentrated under reduced pressure and 
determined to be 3 as a mixture with 20% of the saturated compound. Yield = 67%. 1H NMR 
(CDCl3): į 7.73 (d, J = 7.5 Hz, 1H, Ar-H), 7.56 (td, J = 7.5 Hz, J = 1.1 Hz, 1H, Ar-H), 7.46 (d, 
J = 7.0 Hz, 1H, Ar-H), 7.35 (td, J = 8.5 Hz, J = 1.5 Hz, 1H, Ar-H), 4.83 (br d, 1H, NH), 4.16 
(d, J = 6.1 Hz, 2H, CH2), 3.80 (q, J = 7.0 Hz, 6H, 3xCH2), 3.71 (m, 1H, CH), 3.19-2.90 (m, 2H, 
CH2), 1.79-1.40 (m, 2H, CH2), 1.34 (d, J = 6.9 Hz, 3H, CH3), 1.21 (t, J = 7.0 Hz, 9H, 3xCH3), 
0.67 – 0.52 (m, 2H, CH2).13C NMR (CDCl3): į 156.1 (C), 150.7 (C), 137.5 (C), 132.6 (CH), 
127.9 (CH), 127.3 (CH), 124.0 (CH), 68.6 (CH2), 58.4 (CH2), 43.3 (CH2), 33.2 (C), 23.2 (CH2), 
18.0 (CH3), 17.4 (CH3), 7.5 (CH2). 
 
1-(3,5-Dimethoxyphenyl)-2-oxo-2-phenylethyl 3-butenoate (4): 3',5'-Dimethoxybenzoin 
(obtained according to the literature)4 (490 mg, 1.8 mmol), N,N´-dicyclohexylcarbodiimide 
(520 mg, 2.5 mmol), and 4-dimethylaminopyridine (DMAP) (22 mg, 0.18 mmol) were 
dissolved in anhydrous chloroform (20 mL). The mixture was heated and then 3-butenoic acid 
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was added (196 mg, 2.16 mmol). The reaction was kept under reflux for 12 h. Ethyl acetate 
was added, and the mixture was washed with 10% HCl (20 mL) and aqueous bicarbonate 
solution. The organic layer was dried over MgSO4, filtered, and concentrated. The residue was 
purified by flash chromatography (hexane:AcOEt, 1:1) to give 320 mg (yield = 52%) of 4 as a 
colorless oil. 1H NMR (CDCl3): į 7.94 (d, J = 7.1 Hz, 2H, Ar-H), 7.51 (d, J = 7.5 Hz, 1H, Ar-
H), 7.40 (t, J = 7.4 Hz, 2H, Ar-H), 6.76 (s, 1H, CH), 6.59 (d, J = 2.2 Hz, 2H, Ar-H), 6.42 (s, 
1H, Ar-H), 6.07 – 5.83 (m, 1H, CH), 5.25- 5.18 (m, 2H, CH2), 3.79 (d, J = 16.1 Hz, 6H, 
2xCH3), 3.43 – 3.02 (m, 2H, CH2). 
 
1-(3,5-Dimethoxyphenyl)-2-oxo-2-phenylethyl-4-(triethoxysilyl)butanoate (BNZ-CPTS) (5). 
Product 4 (1.19 g, 3.5 mmol) and triethoxysilane (6.8 mL, 35 mmol) were placed into a 
previously HMDS-passivated3 dry, round-bottomed ﬂask and heated under an argon 
atmosphere to about 80 °C. After the addition of an isopropanolic H2PtCl6 solution (50 μL, 
0.027 mg/μL), the mixture was allowed to react for 4 h at 80 °C and then cooled to room 
temperature. Excess triethoxysilane was removed in vacuum. The crude was purified by a 
previously HMDS-passivated flash chromatography (hexane: ethyl acetate, 3.2:0.8) with a Rf 
of 0.42. Fractions were concentrated and the silane 5 was obtained as a brown oil (0.76 g, 44 
%). 1H NMR (CDCl3): į 7.94 (d, J = 8.2 Hz, 2H, Ar-H), 7.62 – 7.33 (m, 3H, Ar-H), 6.75 (s, 
1H, CH), 6.59 (s, 2H, Ar-H), 6.41 (s, 1H, Ar-H), 3.76- 3.85 (m, 12H, 3xCH2 and 2xCH3), 2.54-
2.49 (m, 2H, CH2), 1.85-1.77 (m, 2H, CH2), 1.23 (t, J = 7.1 Hz, 9H, 3xCH3), 0.68-0.73 (m, 2H, 
CH2). 13C NMR (CDCl3): į 194.0 (C), 172.9 (C), 161.2 (C), 135.7 (C), 134.7 (C), 133.4 (CH), 
128.8 (CH), 106.6 (CH), 101.1 (CH), 79.5 (CH), 58.4 (CH2), 55.4 (CH3), 36.8 (CH2), 18.3 
(CH3), 17.9 (CH2), 10.0 (CH2).
 
7-(Diethylamino)-2-oxo-2H-chromene-4-carbaldehyde (6) was obtained according to 
previously reported procedure.5 Selenium (IV) dioxide (1.10 g, 10 mmol) was added to a 
solution of 7-(diethylamino)-4-methyl-coumarin (2.06 g, 8.9 mmol) in xylene (25 mL, mixture 
of isomers). The reaction mixture was heated under reﬂux with vigorous stirring for 3 hours. 
The brown mixture was allowed to cool to room temperature and a second portion of selenium 
(IV) oxide (1.10 g, 10 mmol) was added. The system was refluxed again during 3 hours. Then, 
the solvent was removed carefully under reduced pressure. The dark-brown residual oil was 
dissolved in acetone and the dark solid was filtered off. The obtained dark-orange solid after 
concentrating was purified by column chromatography using hexane:acetone (4:1). The 
appropriate fractions were collected and the solvents were removed to give a yellow solid as 
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the product 6 (620 mg, 28%). 1HNMR (CDCl3): į 10.03 (s, 1H, CHO), 8.30 (d, J = 9.2 Hz, 1H, 
Ar-H), 6.60 (dd, J = 9.2 Hz, J= 2.6 Hz, 1H, Ar-H), 6.51 (d, J = 2.6 Hz, 1H, Ar-H), 6.46 (m, 1H, 
Ar-H), 3.43 (q, J = 7.1 Hz, 4H, 2xCH2), 1.22 (t, J = 7.1 Hz, 6H, 2xCH3). 
 
7-(Diethylamino)-4-(hydroxymethyl)-2H-chromen-2-one (7) was synthesised according to a 
reported protocol.6 Product 6 (620 mg) was dissolved in isopropanol (50 mL) and then sodium 
borohydride (1.5 eq.) was added. The solution was stirred for 1 h at room temperature and the 
reaction was followed by thin layer chromatography (TLC). Once product 6 can not be noticed 
ethyl acetate (100 mL) and water (150 mL) were added. The red solution was extracted with 
ethyl acetate (2x100 mL). The combined organic extracts were washed with water and brine 
(saturated sodium chloride) and dried over anhydrous sodium sulfate. Removal of the solvent 
under reduced pressure gave a dark-brown oil. Column chromatography using hexane:acetone 
(3:1) as the eluent afforded desired alcohol 7 (320 mg, 51%). 1HNMR (CDCl3): į 7.32 (d, J = 
8.9 Hz, 1H, Ar-H), 6.60 (dd, J = 8.9 Hz, J= 2.6 Hz, 1H, Ar-H), 6.51 (d, J = 2.6 Hz, 1H, Ar-H), 
6.25 (m, 1H, Ar-H), 3.40 (q, J = 7.1 Hz, 4H, 2xCH2), 1.20 (t, J = 7.1 Hz, 6H, 2xCH3). 
 
O-(7-(Diethylamino)-2-oxo-2H-chromen-4-yl)methyl S-3-(triethoxysilyl)propyl carbonothioate 
(DEACM-TPTS) (8). Product 7 was dissolved in dry dichloromethane (40 mL). 4-
dimethylaminopyridine (0.53 g, 4.3 mmol) and 4-nitrophenylchloroformate (0.462 g, 2.3 
mmol) were added and the yellow solution was stirred at room temperature. After 18 h stirring 
the formation of the carbamate intermediate was conﬁrmed by 1H NMR, with the observed 
shift of the signals attributed to Ar-CH2-O from 4.83/4.84 ppm in alcohol 7 to 5.22 ppm in the 
carbamate. 4-DMAP (0.258 g, 2.11 mmol), 3-(mercaptopropyl) triethoxysilane (0.582 mL, 2.4 
mmol) and triethylamine (1.35 mL, 9.69 mmol) were then added to the stirring solution. After 
24 h at room temperature, dichloromethane was evaporated. The obtained orange crude was 
purified by chromatography using HMDS-passivated silica gel3 as support and 
dichloromethane:ethyl acetate (1:0.2, Rf 0.33) as eluent. The residual yellow solid (0.82 g, 
73%) was the desired product 8. 1H NMR (CDCl3): į 7.25 (d, J = 7.5 Hz, 1H, Ar-H), 6.56 (d, J 
= 9.0 Hz, 1H, Ar-H), 6.49 (d, J = 2.5 Hz, 1H, Ar-H), 6.11 (br s, 1H, NH), 5.30 (d, J = 3.5 Hz, 
2H, CH2), 3.81 (q, J = 7.0 Hz, 6H, 3xCH2), 3.40 (q, J = 7.0 Hz, 4H, 2xCH2), 2.94 (dd, J = 8.4 
Hz, 15.8, 2H, CH2), 1.76 (m, 2H, CH2), 1.36 – 1.14 (m, 15H, 5x CH3), 0.78 – 0.64 (m, 2H, 
CH2). 13C NMR (CDCl3): į 172.5 (C), 155.7 (C), 150.7 (C), 150.5 (C), 124.6 (CH), 122.6 (C), 
108.9 (C), 106.4 (CH), 61.8 (CH2), 58.7 (CH2), 45.0 (CH2), 43.1 (CH2), 18.2 (CH3), 14.6 
(CH2), 12.6 (CH3), 7.9 (CH2). 
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5,7-Dinitroindoline-1-carbonyl chloride (9) and 5-bromo-7-nitroindoline-1-carbonyl chloride 
(10) were prepared as previously reported.7 
 
N-Allyl-5,7-dinitroindoline-1-carboxamide (11) and N-allyl-5-bromo-7-nitroindoline-1-
carboxamide (12) were synthesised according to a reported protocol.7-8 Allyl amine (0.28 mL, 
3.68 mmol) was added dropwise to the stirred solution of 5,7-dinitroindoline-1-carbonyl 
chloride (1.00 g, 3.68 mmol) and 4-dimethylaminopyridine (1.12 g, 9.20 mmol) in anhydrous 
CH2Cl2. The mixture was stirred overnight at room temperature and then washed with 3% HCl 
solution (2x40 mL) and 3% NaHCO3 solution (2x40 mL). The organic layer was dried over 
MgSO4, filtered and concentrated. The crude was chromatographed on silica gel 
(EtOAc:petroleum ether, 1:1) to get 11 as a yellow solid (0.51 g, 47% yield). Similar procedure 
was followed in order to obtain N-allyl-5-bromo-7-nitroindoline-1-carboxamide (12) product. 
The stoichiometry relation of  5-bromo-7-nitroindoline-1-carbonyl chloride:allyl amine:4-
DMAP used was 1:10:10. Compound 12 was obtained as an orange solid after purification by 
chromatography (0.76 g, 71%). 1H NMR of 11 (CDCl3): į 8.61 (m, 1H, Ar-H), 8.18 (m, 1H, 
Ar-H), 5.87 (m, 1H, CH), 5.24 (m, 2H, CH2), 5.07 (br d, 1H, NH), 4.28 (t, J = 8.4 Hz, 2H, 
CH2N), 3.94 (m, 2H, CH2-NH), 3.37 (t, J = 8.4 Hz, 2H, CH2). 1H NMR of 12 (CDCl3): į 7.80 
(m, 1H, Ar-H), 7.45 (m, 1H, Ar-H), 5.88 (m, 1H, CH), 5.20 (m, 2H, CH2), 4.76 (br d, 1H, NH), 
4.16 (t, J = 8.7 Hz, 2H, CH2N), 3.92 (m, 2H, CH2-NH), 3.25 (t, J = 8.7 Hz, 2H, CH2). 
 
5,7-Dinitro-N-(3-(triethoxysilyl)propyl)indoline-1-carboxamide  (DNI-APTS) (13) and 5-
Bromo-7-nitro-N-(3-(triethoxysilyl)propyl)indoline-1-carboxamide  (BNI-APTS) (14).  
Silanization of the ureas 11 and 12 was carried out following same synthetic strategy as used in 
the synthesis of 3; resulting in a 68% mixture with the reduced compound for product 13 
(yield= 82%) and in a 65% mixture for product 14 (yield= 84%). 1H NMR of 13 (CDCl3): į 
8.61 (m, 1H, Ar-H), 8.18 (m, 1H, Ar-H), 4.90 (br d, 1H, NH), 4.25 (t, J = 8.6 Hz, 2H, CH2N), 
3.86 (q, J = 7.0 Hz, 6H, 3xCH2), 3.35 (m, 4H, 2xCH2), 1.79-1.51 (m, 2H, CH2), 1.23 (t, J = 7.0 
Hz, 9H, 3xCH3), 0.75 – 0.65 (m, 2H, CH2). 13C NMR of 13 (CDCl3): į 155.3 (C), 144.0 (C), 
142.9 (C), 142.4 (C), 137.2 (C), 123.4 (CH), 120.5 (CH), 59.2 (CH2), 51.5 (CH2), 43.0 (CH2), 
28.2 (CH2), 23.2 (CH2), 18.6 (CH3), 11.2 (CH2).1H NMR of 14 (CDCl3): į 7.80 (m, 1H, Ar-H), 
7.45 (m, 1H, Ar-H), 4.13 (t, J = 8.4 Hz, 2H, CH2N), 3.74 (q, J = 7.0 Hz, 6H, 3xCH2), 3.27 (m, 
4H, 2xCH2), 1.81-1.42 (m, 2H, CH2), 1.24 (t, J = 7.0 Hz, 9H, 3xCH3), 0.76 – 0.62 (m, 2H, 
CH2). 13C NMR of 14 (CDCl3): į 155.6 (C), 139.1 (C), 132.9 (C), 132.4 (C), 131.9 (C), 121.4 
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(CH), 118.5 (CH), 58.7 (CH2), 51.3 (CH2), 44.0 (CH2), 28.0 (CH2), 23.2 (CH2), 18.5 (CH3), 
10.5 (CH2). 
 
D-Bromo-4-hydroxyacetophenone (15) was obtained as previously reported.9  
 
2-(4-Hydroxyphenyl)-2-oxoethyl but-3-enoate (16) was prepared by esterification of 5 with 3-
butenic acid in the presence of 1,8-diazabycyclo[5.4.0.]undec-7-ene (DBU). Butenoic acid 
(0.42 mL, 4.80 mmol) was added to a solution of D-bromo-acetophenone (1.05 g. 4.80 mmol) 
in 1,4-dioxane (100 mL), which was cooled to 0 °C. Then the addition of  DBU (0.81 mL, 5.40 
mmol) was followed dropwise for 10 min. The reaction mixture was allowed to reach room 
temperature and after that the mixture was stirred overnight. Thin layer chromatography (TLC) 
indicated that the reaction was complete. Mixture was filtered and solvent was removed in 
vacuo. The crude product was purified by silica gel column chromatography using as eluent 
dichloromethane:ethyl acetate (10:1). After collection of appropriate fractions for the product, 
the solvent was concentrated to give a white solid as the product 16 (630 mg, 60%). 1H NMR 
(CDCl3): į 7.78 (dt, J = 8.8 Hz, J = 2.0 Hz, 2H, Ar-H), 7.13 (br d, 1H, OH), 6.88 (dt, J = 8.8 
Hz, J = 2.0 Hz, 2H, Ar-H), 5.96 (m, 2H, CH), 5.32 (s, 2H, CH2), 5.24 (m, 2H, CH2), 3.30 (dt, J 
= 6.9 Hz, J = 1.4 Hz, 2H, CH2). 
 
2-(4-Hydroxyphenyl)-2-oxoethyl-4-(triethoxysilyl)butanoate (pHP-CPTS) (17). Product 16 (267 
mg, 1.21 mmol) was dissolved in 4 mL of toluene and placed into a previously HMDS-
passivated3 dry, round-bottomed flask and heated under an argon atmosphere to about 70 °C. 
Then, triethoxysilane (2.23 mL, 12.1 mmol) was added to the solution. After the addition of 
isopropanolic H2PtCl6 solution (62 ȝL, 65 mM), the mixture was stirred for 5 hours at 70 °C 
and then allowed to cool down. Excess of triethoxysilane was removed in vacuum, and the 
residue was taken up in toluene and filtered through Celite500. The filtrate was concentrated 
under reduced pressure to give product 17 in a 61% mixture with the reduced compound (450 
mg, 97%). 1H NMR (CDCl3): į 7.86 (m, 2H, Ar-H), 7.07 (m, 2H, Ar-H), 6.90 (br d, 1H, OH), 
5.29 (s, 2H, CH2), 3.84 (m, 6H, 3xCH2), 2.52 (m, 2H, CH2), 1.94-1.72 (m, 2H, CH2), 1.22 (m, 
6H, 3xCH2), 0.80 – 0.68 (m, 2H, CH2). 13C NMR (CDCl3): į 190.8 (C), 173.2 (C), 159.1 (CH), 
130.1 (C), 119.6 (CH), 115.7 (CH), 65.6 (CH2), 59.2 (CH2), 36.5 (CH2), 18.1 (CH3), 13.1 
(CH2), 10.1 (CH2). 
 
Passivation of Glassware 
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Glass reaction vessels used for silanization were previously passivated either by leaving them 
in a desiccator overnight under vacuum and in the presence of HMDS or by wetting the glass 
surface with pure HMDS, washing with THF and drying in the oven. This step avoids 
undesired reactant consumption during surface silanization due to the condensation of the 
triethoxysilane groups with the free Si-OH groups at the surface of the glass reactors. 
 
Substrate Cleaning 
Quartz and silicon slides 1 x 2.5 cm2 were cut and cleaned by soaking them in Piranha solution 
(H2SO4 (conc.)/H2O2 (30%) 5/1) overnight and subsequent rising with MilliQ-water and drying 
in vacuum at 90 ºC for 1 hour. 
 
Surface Modification 
A 1% w/v solution of the photosensitive silane in THF with 5-20 Pl of 1 N NaOH (aq.) was 
stirred between 30 min and 1 hour. The solution was filtrated through a 0.2 ȝm pore-size PTFE 
filter in the reaction vessel, and clean substrates were immersed in it. After reaction, the 
substrates were rinsed with THF and Milli-Q water and baked for 1 h at 90 ºC in a vacuum 
oven and stored in the dark. Experiments with increasing catalyst concentration and deposition 
times were performed to obtain layers with a maximum density of functional groups (as 
revealed by UV spectroscopy). Before further application, all substrates were sonicated in THF 
for 3 min, washed with Milli-Q water and dried under N2 stream. 
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Fig A.: Spectra of the irradiation sources: (a) LUMOS 43 (Atlas Photonics Inc.), (b) 
Polychrome V system (TILL Photonics GmbH, Gräfelting, Germany) 
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Figure B. Normalized UV-Vis spectra of caged surfaces with different chromophores before 
and after full exposure at 255 nm. 
 
200 250 300 350 400 450 500
0,000
0,004
0,008
0,012
0,016
0,020
Ab
so
rb
a
n
ce
 
(a.
u
.
)
Wavelength (nm)
                                                   * [molec cm-2]
 Blank                                   
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 DNI-APTS; t=0 min               4,01x1014
 DNI-APTS; t=120 min           2,72x1014
 BNI-APTS; t=0 min               2,78x1014
 BNI-APTS; t=120 min           2,06x1014
 pHP-CPTS; t=0 min              7,21x1014
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Figure C. Conversion (%) of the photocleavage of DNI-APTS (13) at the surface upon 
irradiation at 358 nm in absence and presence of a water containing solvent. 
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Table A. Calculated values of the productHOI for the caged organosilanes obtained by fitting 
the experimental conversion data following reference.10 
 
Cages Oirradiation (nm) adir(a) (J-1cm2) HOIb)(M-1cm-1) HOc) (M-1cm-1) 
255 1.52 310 3203 
275 2.67 504 1295 
300 2.14 370 2245 
345 2.52 380 2555 
360 0.67 97 2241 
412 0.34 43 69 
420 0.005 0.61 30 
NVOC (1) 
435 0.002 0.30 14 
NPPOC (3) 255 5.73 1167 3779 
255 40.44 8239 5949 
275 21.18 4001 2829 
300 6.96 1206 1185 
350 1.77 263 72 
BNZ (5) 
360 0.40 65 25 
255 2.54 517 4603 
275 0.72 136 1098 
300 0.40 69 1123 
345 0.90 135 3494 
360 0.52 75 6194 
412 1.00 126 1811 
420 0.02 2.2 783 
DEACM (8) 
435 0.008 0.91 105 
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255 2.89 589 3613 
275 1.17 221 1341 
300 0.98 170 2725 
358 0.88 128 7478 
360 0.58 84 8147 
412 1.88 237 372 
420 0.01 1.09 365 
DNI (13) 
435 0.002 0.27 98 
255 1.89 385 11868 
366 0.63 89 2231 BNI (14) 
360 0.33 47 2148 
255 2.65 540 4225 
275 7.30 1379 5487 pHP (17) 
300 8.51 1473 305 
(a) Values extracted from the fits to the plots conversion versus energy dose for the different protecting 
groups and wavelengths with the equation y = 1-exp(-adir x). 
(b) Data calculated according to the equation adir=1/fEJ [ln(10) HOI], where fEJ is the conversion factor from 
Einstein to Joule, as previously reported.10 
(c) Absorption coefficients of the chromophores IN SOLUTION at the corresponding wavelength 
 
Table B. Reported photolysis quantum yields for different cages. 
  
Caging group Caged functionality I Omax[nm] (İ [M-1 cm-1]) 
NVOC (carbamate) Amine §0.02311 350 (2499) 
NPPOC (carbonate) Carboxylic acid §0.412 355 (331) 
BNZ (carboxyl) Carboxylic acid §0.6413 247 (6388) 
DEACM (phosphate ester) Phosphate §0.2014 385 (7805) 
DNI (amide) Carboxylic acid §0.5015 358 (7478) 
BNI (amide) Carboxylic acid <0.0115 366 (2231) 
pHP (phosphate ester) Phosphate §0.7716 280 (4733) 
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